Caris Life Sciences, Inc.
CAINASDAQHealthcareBiotechnology

About Caris Life Sciences

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company’s molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Company Information

CEODavid Halbert
Founded2008
IPO DateJune 18, 2025
Employees1,769
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone866 771 8946
Address
750 West John Carpenter Freeway, Suite 800 Irving, Texas 75039 United States

Corporate Identifiers

CIK0002019410
CUSIP142152107
ISINUS1421521071
EIN85-2077369
SIC8071

Leadership Team & Key Executives

Dr. David Dean Halbert M.D.
Chairman, Chief Executive Officer and Founder
Brian J. Brille J.D.
Executive Vice Chairman and Executive Vice President
Dr. David Spetzler M.B.A., M.S., Ph.D.
President
Luke Power
Senior Vice President, Chief Financial Officer and Chief Accounting Officer
Jon Mark Harmon
Senior Vice President and Chief Operations Officer
Dr. Valeriy Domenyuk
Senior Vice President and Chief Technology Officer
Dr. Milan Radovich Ph.D.
Senior Vice President and Chief Scientific Officer
Ginger Appleberry J.D.
Senior Vice President, Deputy General Counsel and Chief Compliance Officer
J. Russel Denton
Senior Vice President, General Counsel and Secretary
Narendra Chokshi
Senior Vice President of Corporate Development